Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations,® aims to promote awareness of the major democratic principles on which tolerance is based.

Researchers: Ebola Vaccine Trials 'Very Satisfactory' So Far

Almost 200 people have received GlaxoSmithKline's experimental Ebola vaccine in trials in the United States, Britain, Mali and Switzerland, and the safety data so far are “very satisfactory,” scientists said on Monday. The trials, which began just over two months ago, have been using healthy volunteers, rather than patients with Ebola, to test whether the vaccine is safe for humans. The experimental shot uses a single Ebola virus gene from a chimpanzee virus to generate an immune...

Read complete article
© Voice of America -

Follow us on ...
Facebook Twitter